orantinib has been researched along with ag 1295 in 1 studies
| Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (ag 1295) | Trials (ag 1295) | Recent Studies (post-2010) (ag 1295) |
|---|---|---|---|---|---|
| 110 | 19 | 36 | 17 | 0 | 4 |
| Protein | Taxonomy | orantinib (IC50) | ag 1295 (IC50) |
|---|---|---|---|
| Dihydrofolate reductase | Homo sapiens (human) | 6.2 | |
| Dihydrofolate reductase | Mus musculus (house mouse) | 6.2 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 6.2 | |
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 3.7333 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 6.26 | |
| Dihydrofolate reductase | Pneumocystis carinii | 6.2 | |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | 2.9 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 6.2 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 1.1 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gangjee, A; Ihnat, MA; Raghavan, S; Thorpe, JE; Yang, J; Zaware, N | 1 |
1 other study(ies) available for orantinib and ag 1295
| Article | Year |
|---|---|
N⁴-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation.
Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Design; Humans; Indoles; Mice; Mice, Nude; Molecular Dynamics Simulation; Neoplasms; Oxindoles; Propionates; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Transplantation, Heterologous; Vascular Endothelial Growth Factor Receptor-2 | 2012 |